CompletedNCT00597168
Quality of life during antipsychotic treatment in schizophrenia
About this title
Read the official source — NCT00597168Observational studyAges 18–65Belgium
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Aalst and 44 more locationsSee all locations and recruitment
Study information
Study start dateOctober 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 124
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Locations
- Belgium
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00597168
- Official title
Show the full official title
QUALITY: A Non-interventional Study Evaluating Quality Of Life in Schizophrenic Patients Treated With Atypical Antipsychotics, in the Ambulatory Setting. A 9-month, Observational, Multicentric Prospective Study.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Aalst · Asse · Bertrix
42 more locations
- Bierbeek
- Boechout
- Bon-Secours
- Brussels
- Dendermonde
- Diest
- Duffel
- Eeklo
- Embourg
- Floreffe
- Ghent
- Halle
- Henri-Chapelle
- Herstal
- Ixelles-Elsene
- Jambes
- Kortenberg
- Kortrijk
- La Louvière
- Leut
- Leuven
- Libramont
- Lierneux
- Liège
- Melle
- Menen
- Mol
- Mons
- Ostend
- Ottignies
- Roeselare
- Schaarbeek
- Sint-Kruis (Brugge)
- Sint-Michiels
- Sint-Niklaas
- Sint-Truiden
- Sleidinge
- Tielt
- Tienen
- Veurne
- Waregem
- Woluwe-Saint-Lambert
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Who was this study for?
Listed age limits: 18 years to 65 years.
